Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FF-31501 in Meniscus Tear
NCT05777967Phase 3Active, not recruiting
- Sponsor
- FUJIFILM Toyama Chemical
- Start
- Jan 2023
- Primary completion
- Dec 2024
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
A Phase 3 trial of FF-31501 in Meniscus Tear (MT), sponsored by FUJIFILM Toyama Chemical. Started Jan 2023; status: active, not recruiting.
02
Drugs
FF-31501
03
Conditions
Meniscus Tear (MT)
Beyond the preview
Go deeper on NCT05777967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05777967.